Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims
Tuesday, February 08, 2022Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd and its affiliates has reached an agreement with the Attorney General AG of Texas that settles the states and its subdivisions opioidrelated claims Under the terms of the settl...
Azurity Pharmaceuticals, Inc. Announces FDA Approval Of Fleqsuvy™
Tuesday, February 08, 2022Azurity Pharmaceuticals Inc a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved conditions today announced the US Food and Drug Administration FDA approval of FLEQ...
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates
Friday, February 04, 2022Mersana Therapeutics Inc a clinicalstage biopharmaceutical company focused on discovering and developing a pipeline of antibodydrug conjugates ADCs targeting cancers in areas of high unmet medical need today announced a research collaboration and lic...
Dyve Biosciences Announces Research and Development Collaboration with Moffitt Cancer Center
Friday, February 04, 2022Dyve Biosciences Inc Dyve a clinicalstage biotech company applying its proprietary transdermal delivery technology to a broad pipeline of clinical assets today announced a joint twoyear research collaboration with Moffitt Cancer Center The collaborat...
Syros Receives FDA Orphan Drug Designation for Tamibarotene for the Treatment of MDS
Thursday, February 03, 2022Syros Pharmaceuticals a leader in the development of medicines that control the expression of genes today announced that the US Food and Drug Administration FDA has granted orphan drug designation ODD to tamibarotene for the treatment of myelodysplas...
Vericel Announces Plans for a New State-of-the-Art Cell Therapy Manufacturing Facility to Support Long-Term Growth
Thursday, February 03, 2022Vericel Corporation a leader in advanced therapies for the sports medicine and severe burn care markets today announced that it has entered into a longterm lease agreement for a new stateoftheart advanced cell therapy manufacturing and corporate head...
BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology
Wednesday, February 02, 2022German independent research institute BioMed X announces today the extension of its collaboration with Merck KGaA Darmstadt Germany in the research project RNA Splicing in Cancer RSC As a result of the successful research work to date Merck KGaA Darm...
Coriolis Pharma Opens New ATMP Formulation Development Facilities
Wednesday, February 02, 2022Coriolis Pharma a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines today announced the opening of its new ATMP development facilities under biosafety level S B...
Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to Advance Care for Cancer Patients
Tuesday, February 01, 2022Leica Biosystems a cancer diagnostics company has entered into an agreement with Leap Therapeutics NASDAQ LPTX a biotechnology company to develop a companion diagnostic to detect Dickkopfrelated protein DKK The assay will be used to support clinical...
Oxford Biomedica announces that Sio Gene Therapies intends to cease the license agreement for gene therapy programme in Parkinson’s disease
Tuesday, February 01, 2022Oxford Biomedica plc a leading gene and cell therapy group announced today that it was informed on Monday January by Sio Gene Therapies Sio that Sio intends to return the global rights for AXOLentiPD and that they intend to cease work on this gene t...
